Dermapharm Holding SE
DMPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,130 | $1,798 | $1,970 | $2,224 |
| - Cash | $172 | $163 | $115 | $121 |
| + Debt | $1,186 | $1,010 | $995 | $980 |
| Enterprise Value | $3,144 | $2,645 | $2,850 | $3,083 |
| Revenue | $346 | $272 | $302 | $291 |
| % Growth | 27.2% | -10% | 4% | – |
| Gross Profit | $126 | $184 | $199 | $193 |
| % Margin | 36.4% | 67.7% | 65.9% | 66.5% |
| EBITDA | $107 | $66 | $83 | $72 |
| % Margin | 30.8% | 24.3% | 27.3% | 24.9% |
| Net Income | $48 | $21 | $33 | $21 |
| % Margin | 14% | 7.7% | 11% | 7.1% |
| EPS Diluted | 0.9 | 0.39 | 0.62 | 0.38 |
| % Growth | 130.8% | -37.1% | 63.2% | – |
| Operating Cash Flow | $52 | $66 | $4 | $72 |
| Capital Expenditures | -$11 | -$10 | -$10 | -$12 |
| Free Cash Flow | $41 | $55 | -$6 | $60 |